Css LLC Incyte Corp Transaction History

Css LLC

$830 Million
Q1 2025

A detailed history of Css LLC transactions in Incyte Corp stock. As of the latest transaction made, Css LLC holds 8,190 shares of INCY stock, worth $642,014. This represents 0.06% of its overall portfolio holdings.

Number of Shares

8,190

Previous 9,940 17.61%

Holding current value

$642,014

Previous $686,000 27.84%

% of portfolio

0.06%

Previous 0.07%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$60.0 - $75.26 $105,000 - $131,705	-1,750 Reduced 17.61%	8,190 $495,000
Q4 2024 Feb 14, 2025	BUY	$65.08 - $83.38 $646,895 - $828,797	9,940 New	9,940 $686,000
Q3 2023 Nov 14, 2023	BUY	$57.77 - $65.93 $361,120 - $412,128	6,251 New	6,251 $361,000
Q1 2018 May 15, 2018	SELL	$83.06 - $100.98 $2.2 Million - $2.67 Million	-26,436 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$93.56 - $116.6 $542,648 - $676,280	-5,800 Reduced 17.99%	26,436 $2.5 Million
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $3.52 Million - $4.46 Million	32,236	32,236 $3.76 Million

Others Institutions Holding INCY

# of Institutions

707

Shares Held

195M

Call Options Held

564K

Put Options Held

317K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $17.4B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.

Account